PP Insider Trading Activity and SEC Form 4 Filings
PP insider trading summary
No open-market insider purchases or sales of Pipex Pharmaceuticals, Inc. (PP) have been reported on SEC Form 4 in the past 12 months.
Latest PP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 11, 2008 | Steve H Kanzer | Chief Executive Officer | Buy | $91 (100 @ $0.91) |
| Apr 11, 2008 | Steve H Kanzer | Chief Executive Officer | Buy | $5K (6,200 @ $0.86) |
| Apr 11, 2008 | Steve H Kanzer | Chief Executive Officer | Buy | $2K (2,650 @ $0.94) |
| Apr 11, 2008 | Steve H Kanzer | Chief Executive Officer | Buy | $450 (500 @ $0.90) |
| Apr 11, 2008 | Steve H Kanzer | Chief Executive Officer | Buy | $405 (500 @ $0.81) |
| Apr 11, 2008 | Steve H Kanzer | Chief Executive Officer | Buy | $850 (1,000 @ $0.85) |
| Apr 11, 2008 | Steve H Kanzer | Chief Executive Officer | Buy | $395 (500 @ $0.79) |
| Apr 11, 2008 | Steve H Kanzer | Chief Executive Officer | Buy | $2K (2,400 @ $0.89) |
| Apr 11, 2008 | Steve H Kanzer | Chief Executive Officer | Buy | $2K (1,866 @ $0.95) |
| Apr 11, 2008 | Steve H Kanzer | Chief Executive Officer | Buy | $9K (9,900 @ $0.92) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.